Levetiracetam

Levetiracetam, the active ingredient in this product, is an antiepileptic presented as a generic formulation for oral and intravenous use. It is used to treat partial, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure control.

GNH USA supplies Levetiracetam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication that acts on neuronal excitability to control various seizure types. - Partial seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: diminishes sudden muscle jerks associated with epilepsy.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Fatigue: generalized tiredness or lack of energy. - Headache: mild to moderate cranial pain. - Irritability: changes in mood or increased agitation. - Nausea: occasional stomach upset. - Nasal congestion: mild upper respiratory irritation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression, suicidal thoughts, or behavioral changes. - Blood disorders: leukopenia or thrombocytopenia. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing Levetiracetam, clinicians should consider several safety aspects. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic dysfunction: monitor liver enzymes during therapy. - Pregnancy: Category B; discuss potential risks with the patient. - Breastfeeding: evaluate benefits versus potential infant exposure. - Psychiatric history: monitor for mood changes or suicidal ideation. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: can lower levetiracetam concentrations. - Phenytoin: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, requiring monitoring. - Rifampin: can modestly reduce levetiracetam concentrations. - Oral contraceptives: monitor for reduced contraceptive effectiveness.